Paclitaxel and doxorubicin, a highly active combination in the treatment of metastatic breast cancer.

Dombernowsky, P; Gehl, J; Boesgaard, M; Jensen, T P; Jensen, B V

Dombernowsky, P; Gehl, J; Boesgaard, M; Jensen, T P; Jensen, B V.

Affiliation

Dombernowsky P; Department of Oncology, Herlev Hospital and Righospitalet, University of Copenhagen, Denmark.

Semin Oncol ; 23(1 Suppl 1): 13-8, 1996 Feb.

Article in En | MEDLINE | ID: mdl-8629030

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Breast Neoplasms/drug therapy; Antibiotics, Antineoplastic/administration & dosage; Antineoplastic Agents, Phytogenic/administration & dosage; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dose-Response Relationship, Drug; Doxorubicin/administration & dosage; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Multicenter Studies as Topic; Paclitaxel/administration & dosage; Randomized Controlled Trials as Topic; United States

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials Limits: Female / Humans Country/Region as subject: America do norte Language: En Journal: Semin Oncol Year: 1996 Document type: Article Affiliation country: Denmark

Search on Google

Add to My VHL

XML

PubMed Links